- Docket No.
- District Court
- Seeking payment owed for COVID-19 diagnostic testing.
Why this Matters
The plaintiff, a clinical lab, argues that a health insurance company’s refusal to properly reimburse for COVID-19 testing services violates the Coronavirus Aid, Relief, and Economic Security (CARES) Act. The CARES Act specifies that health insurers must provide coverage for COVID-19 testing without requiring any cost sharing on the part of patients. It also requires insurers to reimburse testing providers (both in- and out-of-network) for conducting such testing. But the law’s requirement that health insurers pay an out-of-network provider of COVID-19 testing a “cash price” listed on their public website— rather than a market-determined price or amount keyed to Medicare payment rates — has the potential to inflate costs for out-of-network COVID-19 testing.
The lack of guardrails related to capping payment rates for out-of-network COVID-19 testing services can drive up the costs of such testing.
16 Major Filings
- Notice of Appeal (Oct 19, 2022)
- JUDGMENT (Sep 20, 2022)
- Order on Plaintiff Mot. for Partial Summary Judgment and Def Mot to Dismiss (Sep 20, 2022)
- Letter to District Judge by GS Labs (Apr 1, 2022)
- Letter to District Judge by Medical (Mar 17, 2022)
- Letter to District Judge by GS Labs (Mar 15, 2022)
- Reply in Support of Motion to Dismiss (Feb 28, 2022)
- Plaintiff Reply to Def Opp to Motion for Partial Summary Judgment (Feb 14, 2022)
- Memo in Opposition to Motion to Dismiss (Feb 4, 2022)
- Memo in Opposition to Partial Summary Judgment (Jan 14, 2022)
- Order for Party to File Document Respond Reply 29 Motion (Dec 27, 2021)
- Motion to Dismiss (Dec 23, 2021)
- Briefing Order Reply 26 Stipulation (Dec 15, 2021)
- STIPULATION (Dec 8, 2021)
- Motion for Partial Summary Judgment (Nov 12, 2021)
- Complaint (Oct 28, 2021)